Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Structure Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Janux Therapeutics Inc. June 11, 202697.7%
-
Structure Therapeutics Inc. June 23, 202599.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Janux Therapeutics Inc. | Grant or award | +5,500 | — | — |
| Jun 11, 2025 | Janux Therapeutics Inc. | Grant or award | +3,750 | — | — |
| Jul 19, 2024 | Janux Therapeutics Inc. | Grant or award | +5,000 | — | — |
| Jul 19, 2024 | Janux Therapeutics Inc. | Grant or award | +2,500 | — | — |
| Nov 10, 2023 | Atara Biotherapeutics Inc. | Open-market purchase | +446,825 | $0.23 | $102,770 |
| May 31, 2023 | Atara Biotherapeutics Inc. | Grant or award | +57,000 | — | — |
Questions about Eric Dobmeier
What boards is Eric Dobmeier on?
Eric Dobmeier sits on the boards of Atara Biotherapeutics Inc., Jade Biosciences Inc., Janux Therapeutics Inc. and Structure Therapeutics Inc.
How long has Eric Dobmeier served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.